4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001144204-07-050780
10% owner bought 679,048 shares at $1.05 ($713,000)
- 10% owner sold 187,902 shares at an average $2.10 ($394,911)
- 10% owner acquired 547,384 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
ADAMS DONALD E · 10% owner
Table I: Non-derivative
28 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2006-06-08 | Conversion : show line 1 in the form | +518,657 | $0.74 | $382,250 | 5,006,250 | D |
| 2006-06-08 | Conversion : show line 2 in the form | +28,727 | 5,034,977 | D | ||
| 2006-08-11 | Sale : show line 3 in the form | −15,000 | $1.13 | $16,950 | 5,019,977 | D |
| 2007-01-16 | Sale : show line 4 in the form | −6,000 | $1.22 | $7,320 | 5,013,977 | D |
| 2007-01-17 | Sale : show line 5 in the form | −2,000 | $1.23 | $2,460 | 5,011,977 | D |
| 2007-01-22 | Sale : show line 6 in the form | −6,000 | $1.20 | $7,200 | 5,005,977 | D |
| 2007-01-24 | Sale : show line 7 in the form | −1,500 | $1.20 | $1,800 | 5,004,477 | D |
| 2007-01-27 | Purchase : show line 8 in the form | +679,048 | $1.05 | $713,000 | 5,683,525 | D |
| Open-market purchases · 679,048 sh · avg $1.05 · $713,000 | ||||||
| Open-market sales · 187,902 sh · avg $2.10 · $394,911 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2006-06-08 | Conversion : show line 29 in the form $382,250 8% Convertible Note | +547,384 | $0.74 | $403,422 | $0.74 | 2006-11-26 | 547,384 | 0 | D |
Loading xslF345X02/v087678_ex.xml…